Videja

Videja Therapeutics is a biotechnology company dedicated to developing precision medicines for patients suffering from autoimmune and inflammatory diseases. The company utilizes a proprietary platform to identify and target specific molecular drivers of disease, aiming to provide more effective and safer therapeutic options than current standards of care. By combining advanced computational biology with deep expertise in immunology, Videja seeks to accelerate the discovery and development of novel drug candidates. The company is currently in the pre-clinical stage, focusing on building a robust pipeline of targeted therapies.